What are the survival outcomes of immunotherapy treatment for colorectal cancer in low and middle income countries?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18744307
Cited by: 0

Abstract

Survival outcomes for colorectal cancer using immunotherapy in low and middle-income countries are not well-documented, with existing studies indicating potential efficacy, yet more region-specific research is needed to confirm these findings.

Fields of Study & Subjects

Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers Colorectal Cancer Surgical Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
23 February 2026
Language
EN